Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 14,721–14,740 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

METHYCOBALAMIN, preservative, 1mg/mL, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

METHYCOBALAMIN, preservative free, 20mg/mL, injectable, 0.3 mL or 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

METHYCOBALAMIN, preservative free, 1mg/mL, injectable, 2 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

METHYCOBALAMIN, preservative free, 10mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

LIDOCAINE HCL (REPKG-STERILE), 4%, solution for irrigation, 5 mL, 6 mL, and 7 mL plastic dropper bottle, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXYPROGESTERONE CAPROATE (SESAME OIL), 250mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXOCOBALAMIN- preservative (B12), 1mg/mL, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXOCOBALAMIN-preservative free (B12), 1mg/mL, injectable, 2 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

HYALURONIDASE, 240 u/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

GLUTATHIONE, 100 mg/mL, injectable, 100 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

GLUTATHIONE with preservative, 100mg/mL, injectable, 100 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

GLUTARALDEHYDE BUFFERED (POTASSIUM PHOSPHATE), solution for irrigation, 250 mL glass bottle, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

GENTAMICIN SULFATE, 480mg/1000mL, solution for irrigation, 300 mL plastic bottle, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

GANCICLOVIR, preservative free, 0.2mg/0.05mL, injectable, 0.1 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

GANCICLOVIR -preservative free, 2mg/0.1mL, injectable, 0.1 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

ESTRADIOL CYPIONATE (COMPOUNDED/GRAPESEED OIL), 5 mg/mL, injectable, 1 ml glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

EPINEPHRINE/WATER, preservative free 1:1000, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

DMPS-preservative free, 50 mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

DEXPANTHENOL with preservative, 250 mg/mL, injectable, 30 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Drug Recall Terminated Historical recordClass II

DEXAMETHASONE (AS SOD PHOS), 24 mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070

by Oregon Compounding Centers, Inc. dba Creative Compounds

Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Recall initiated
October 6, 2014
Reported by FDA
November 12, 2014
Distribution
Oregon, Washington

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.